Astria Therapeutics
ATXS
ATXS
110 hedge funds and large institutions have $523M invested in Astria Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% more call options, than puts
Call options by funds: $631K | Put options by funds: $591K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $622M → $523M (-$98.7M)
Holders
110
Holding in Top 10
1
Calls
$631K
Puts
$591K
Top Buyers
| 1 | +$25.7M | |
| 2 | +$11.7M | |
| 3 | +$3.55M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$1.61M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.26M |
Top Sellers
| 1 | -$8.95M | |
| 2 | -$7.98M | |
| 3 | -$5.02M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.65M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.3M |